Effective treatment with oral sulfonylureas in patients with diabetes due to SUR1 Mutations

Ítems similars

• Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
  per: Babiker, Tarig, et al.
  Publicat: (2016)
• Sulfonylurea Treatment in Young Children with Neonatal Diabetes: Dealing with Hyperglycaemia, Hypoglycaemia and Sickdays
  per: Codner, Ethel, et al.
  Publicat: (2007)
• Mutations in the ABCC8 gene encoding the SUR1 subunit of the K(ATP) channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period
  per: Patch, A.M., et al.
  Publicat: (2007)
• Mutations of the Same Conserved Glutamate Residue in NBD2 of the Sulfonylurea Receptor 1 Subunit of the K(ATP) Channel Can Result in Either Hyperinsulinism or Neonatal Diabetes
  per: Männikkö, Roope, et al.
  Publicat: (2011)
• Mutations in K(ATP) Channel Genes cause Transient Neonatal Diabetes and Permanent Diabetes in Childhood or Adulthood
  per: Flanagan, Sarah E., et al.
  Publicat: (2007)